FluorO2 Therapeutics Overview

  • Founded
  • 2014
  • Status
  • Out of Business
  • Employees
  • 6
  • Latest Deal Type
  • Out of Business

FluorO2 Therapeutics General Information


Manufacturer and supplier of approved artificial blood intended to address the worldwide blood shortage. The company's artificial blood is completely synthetic, non-hemoglobin-based and can be used as a blood substitute in trauma, acute blood loss/hemorrhage, severe anemia, treatment of sickle cell disease, recovery from chemotherapy, and other medical situations, eliminating the possibility of viral transmission and can be given to anyone and does not need to be matched to blood type before administration, saving precious time and resources.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Other Devices and Supplies
Primary Office
  • 160 West Camino Real
  • Suite 263
  • Boca Raton, FL 33432
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

FluorO2 Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Feb-2019 000 Completed Out of Business
2. Equity Crowdfunding 15-Oct-2014 000 000 Completed Startup
1. Equity Crowdfunding Completed Startup
To view FluorO2 Therapeutics’s complete valuation and funding history, request access »

FluorO2 Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial